Clinical trials recruiting for Melanoma (Skin Cancer)

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• 68Ga-SorB PET/CT Imaging in Patients With Solid Tumors
  NCT07760012 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors
  NCT07376707 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Phase II Clinical Trial on Neo-adjuvant Pembrolizumab in Patients With pT3b-T4a/b cN0M0 Melanoma.
  NCT07448831 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks
  NCT07469709 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
  NCT06624644 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• Artificial Intelligence Based Melanoma Early Diagnosis and Risk Prediction in Children, Adolescents and Young Adults
  NCT06621810 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 3 locations
• Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
  NCT07410494 · Phase: Phase 1, Phase 2 · Ages: 8 Years to 85 Years · Sex: All (male and female) · 3 locations
• Clinical Study on High-fiber Diet and Short-term Fasting in Melanoma Under Immunotherapy With Checkpoint Inhibition
  NCT07680452 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Dietary Fiber to Induce Gut Microbiota-mediated Response to Immunotherapy in Melanoma.
  NCT07686835 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
  NCT07410676 · Phase: Phase 1, Phase 2 · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Efficacy and Safety of Neoadjuvant Cadonilimab Plus High-Dose Recombinant Human Interferon α1b in Stage III/IV Melanoma.
  NCT07586904 · Phase: Early Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Exploratory Study With Parallel Controls on the Safety and Efficacy of Neoadjuvant Low Branched-Chain Amino Acid Diet in Combination With Anti-PD-1 Monoclonal Antibody for Stage III Melanoma
  NCT07586891 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition Intervention
  NCT07649681 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• IMmune checkPoint Inhibitor Related gonAdal toxiCiTy in Premenopausal Women and Men With Melanoma
  NCT07138222 · Phase: Not specified · Ages: 18 Years to 60 Years · Sex: All (male and female) · 6 locations
• Investigating Real-Time Immunotherapy Symptoms Study
  NCT07280715 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC
  NCT07718243 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Liquid Biopsy Multi-Omics and Biomarker Development in Melanoma
  NCT07584291 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• NO Re-excision MelanomA - NORMA 2
  NCT07530887 · Phase: Phase 3 · Ages: No age limits stated · Sex: All (male and female) · 21 locations
• Navigation Intervention for Adolescent and Young Adult Cancer Survivors
  NCT07406087 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 45 Years · Sex: All (male and female) · 1 location
• Neoadjuvant Pembrolizumab in Patients With Stage IIb/c Melanoma
  NCT07349303 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Pan-tumor MRD Study
  NCT06605404 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)
  NCT06545682 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy
  NCT07555210 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Precision Medicine for L/GCMN and Melanoma 1
  NCT06608420 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Precision Medicine for L/GCMN and Melanoma 2
  NCT06605443 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
  NCT07327489 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 16 locations
• Reflectance Confocal Microscopy and Molecular Correlation in Atypical Melanocytic Lesions
  NCT07277920 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• SL-28 for Advanced Solid Tumours
  NCT07341737 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
  NCT07287917 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 20 locations
• Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions
  NCT07556380 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Related conditions

Trials recruiting for Melanoma (Skin Cancer) often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Melanoma (Skin Cancer) trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.